Clinical - ABL SA : ABL SA

Read more

EMRs - Registries - Integration tool

Read more

Clinical solutions

Discover our solutions

Clinical applications

Discover our applications

Highly Satisfactory Accuracy for the UltraGene Combo2Screen SARS-CoV-2 Assay on the QCMD 2020 Coronavirus Outbreak Preparedness EQA Pilot Study

May 29, 2020

We are pleased to announce that the UltraGene Combo2Screen SARS-CoV-2 Assay has obtained Highly Satisfactory results (with a 100% accuracy for qualitative detection of all QCMD blinded samples, including with lowest viral load) in the context of the QCMD 2020 Coronavirus Outbreak Preparedness EQA Pi…
Read more
Advanced Biological Laboratories Receives CE-IVD Registration for its UltraGene Combo2Screen SARS-CoV-2 Assay

May 21, 2020

Optimizing COVID-19 management through highly sensitive SARS-CoV-2 detection test. Luxembourg (Luxembourg), Metz (France) — May 21— Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its UltraGene® Combo2Screen SARS-CoV-2 assay, now available for in-vitro diagnostics u…
Read more
Advanced Biological Laboratories Receives CE-IVD Registration for its SANGER and for its NGS DeepChek®-HIV Genotyping Drug Resistance Assays

May 18, 2020

A unique and flexible solution adapted to all virology and microbiology laboratories LUXEMBOURG CITY (Luxembourg), METZ (France) — May 18th, 2020 — Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its DeepChek®-HIV assays, now available for in-vitro diagnostics. Intend…
Read more

UltraGene Combo2Screen SARS-CoV-2 Assay Now Supported by French ANSM

May 13, 2020

Luxembourg (Luxembourg), Metz (France), Boston (USA) — May 13 — Advanced Biological Laboratories (ABL) announced today that its RT-PCR test for COVID-19 detection UltraGene® Combo2Screen SARS-CoV-2 assay is now officially approved by the French ANSM (Agence nationale de sécurité du médicament) as a…
Read more
UltraGene Combo2Screen SARS-CoV-2 Assay Now CE-IVD Marked

May 07, 2020

Luxembourg (Luxembourg), Metz (France), Boston (USA) — May 7— Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its UltraGene® Combo2Screen SARS-CoV-2 assay is now available for in-vitro diagnostics use. This test is intended to be used for the qualitative detection of nuc…
Read more
UltraGene Combo2Screen SARS-CoV-2 Assay Now Validated by the French National Laboratory Network

May 05, 2020

We did in March 2020 an external clinical validation with the French National Reference Centre for Covid-19 (CNR). The validation was in two phases. Clinical samples were tested both with the CNR’s RT-PCR reference method (IP2/IP4) and the UltraGene Combo2Screen SARS-CoV-2 Assay. The two phase…
Read more

AdvancedDx Biological Laboratories Launches in the U.S. to Bring COVID-19 Diagnostic and Antibody Tests to Local Communities

May 01, 2020

NEWBURYPORT, MA – May 1, 2020: AdvancedDx Biological Laboratories USA Inc. (ABLDx), a virologic diagnostic solutions company, announced today its official launch in the U.S. to commercialize solutions that will advance public health in the Americas. The company will be focused on fighting the COVID-…
Read more
100% clinical reproducibility for the UltraGene Combo2Screen SARS-CoV-2 Assay on the QCMD panel!

Apr 30, 2020

We are pleased to announce that the UltraGene Combo2Screen SARS-CoV-2 Assay has been validated by the Quality Control for Molecular Diagnostics (QCMD). The QCMD is an independent International External Quality Assessment (EQA) / Proficiency Testing (PT) organisation, providing wide-ranging quality a…
Read more
Latest Updates on ABL Solutions for SARS-CoV-2 Diagnostics

Mar 31, 2020

Involved in fight against the new Coronavirus, Covid-19, ABL announces the immediat release of new products : UltraGene Combo 3 genes CoV-2 Assay : 3 targeted genes : RdRp & N-gene for detection, E-gene for confirmation UltraGene-CoV-2-Combo-2 : 2 targeted genes : RdRp & N-gene UltraGene E…
Read more